Nociplastic Pain in Patients With Chronic Shoulder Pain
CompletedNCT05481710
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study was to investigate predictors of nociplastic shoulder pain. Factors of psychological distress, functionality, fitness, quality of life, quality of sleep, functioning of the parasympathetic system, and lifestyle will be examined. Patients with nociplastic pain will be identified using the classification system proposed by the IASP.
Study details
- Official title
- Investigation of the Profile of Patients With Chronic Shoulder Pain: A Cross-sectional Study
- Conditions
- Interventions
- Diagnostic test: Nociplastic Pain Criteria
- Sponsor
- Paraskevi Bilika
- Organization
- University of Thessaly
- Start date
- 2022-07-18
- Primary completion
- 2025-01-10
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Greece
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients (men and women) with chronic shoulder pain (lasting more than 3 months, 3/10 Numeric Pain Rating Scale), * aged 18-65 years * mentally able to follow instructions or * healthy volunteers * aged 18-65 * who do not experience pain and have not received analgesic medication in the last trimester. Exclusion Criteria: * referred shoulder pain from different primary sources of pain (eg shoulder pain in women with mastectomy or stroke), * pain manifested by movements in the neck, * shoulder arthroplasty or fractures or dislocation of the shoulder, - * diagnosis of chronic pain syndrome such as fibromyalgia, chronic fatigue syndrome, chronic regional pain syndrome, cancer diagnosis, osteoporosis, rheumatic inflammatory diseases, * use of medication for neurological/psychiatric disorders, * the presence of gastrointestinal or renal disease * taking medication that may affect the assessment results, such as calcium channel blockers that could alter HRV, * pregnancy or childbirth before 1 year will be excluded from the study.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05481710